TITLE

MEDICAGO HOLDS GROUNDBREAKING FOR U.S. VACCINE FACILITY

PUB. DATE
November 2010
SOURCE
Worldwide Biotech;Nov2010, Vol. 22 Issue 11, p7
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
This article reports on the official groundbreaking ceremony held by Medicago U.S.A. Inc. for its U.S. plant-based commercial grade vaccine facility in Research Triangle Park, North Carolina. The ceremony was attended by company executives, U.S. Senator Kay Hagan and U.S. Congressman David Price. Construction for a cyclic guanosine monophosphate (cGMP) facility was started by Medicago in RTP. The target monthly output of the facility is 10 million doses of pandemic influenza vaccine.
ACCESSION #
54993767

 

Related Articles

  • Chronic inhibition of cyclic GMP phosphodiesterase 5A may promote pressure overload-induced chamber dilatation in mice. Eder, Elisabeth; Van Eickels, Martin; Frantz, Stefan; Völker, Katharina; Baba, Hideo A.; Kuhn, Michaela // BMC Pharmacology;2007 Supplement 1, Vol. 7, pP17 

    An abstract of the paper "Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A May Promote Pressure Overload-induced Chamber Dilatation in Mice," by Elisabeth Ederand, Stefan Frantz, and colleagues is presented.

  • cGMP.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p415 

    An encyclopedia entry for the acronym "cGMP," which stands for cyclic guanosine monophosphate, is presented.

  • Abstract not submitted for publication.  // BMC Pharmacology & Toxicology;2013, Vol. 14 Issue Suppl 1, p3 

    The article presents information on non-availability of an abstract for an article presented at the 6th International Conference on cGMP: Generators, Effectors and Therapeutic Implications that was held in Erfurt, Germany from June 28 to 30, 2013.

  • Fishing for elusive cCMP-degrading phosphodiesterases. Schneider, Erich; Kuhn, Maike; Reinecke, Daniel; Wolter, Sabine; Burhenne, Heike; Kaever, Volkhard; Seifert, Roland // BMC Pharmacology & Toxicology;2013, Vol. 14 Issue Suppl 1, p1 

    An abstract of the article "Fishing for elusive cCMP-degrading phosphodiesterases" by Erich Schneider and colleagues, from the 6th International Conference on cGMP: Generators, Effectors and Therapeutic Implications, is presented.

  • Structure of the GAF domain, a ubiquitous signaling motif and a new class of cyclic GMP receptor. Ho, Yew-Seng J.; Burden, Lisa M.; Hurley, James H. // EMBO Journal;3/15/2001, Vol. 20 Issue 6, p1483 

    Presents a correction to the article "Structure of the GAF Domain, a Ubiquitous Signaling Motif and a New Class of Cyclic GMP Receptor," by Vew-Seng J. Ho, Lisa M. Burden and James H. Hurley.

  • An unusual cGMP pathway underlying depolarizing light response of the vertebrate parietal-eye photoreceptor. Xiong, Wei-Hong; Solessio, Eduardo C.; Yau, King-Wai // Nature Neuroscience;Sep98, Vol. 1 Issue 5, p359 

    All cellular signaling pathways currently known to elevate cGMP involve the activation of a guanylyl cyclase to synthesize cGMP. Here we describe an exception to this rule. In the vertebrate parietal eye, the photoreceptors depolarize to light under dark-adapted conditions, unlike rods and cones...

  • Differential Expression of Functional Guanylyl Cyclases in Melanocytes: Absence of Nitric-Oxide-Sensitive Isoform in Metastatic Cells. Ivanova, Krassimira; Das, Pranab K.; van den Wijngaard, Rene M. J. G. J.; Lenz, Wolfgang; Klockenbring, Torsten; Malcharzyk, Vanessa; Drummer, Christian; Gerzer, Rupert // Journal of Investigative Dermatology;Mar2001, Vol. 116 Issue 3, p409 

    Summary Nitric oxide (NO) is a reactive endogenous molecule with multiple functions and its cellular signaling activity is mainly mediated by activation of the soluble isoform of guanylyl cyclase, a heterodimeric (α/β) hemeprotein. The expression of the NO-sensitive soluble isoform of...

  • Erratum: “Estimating the rate constant of cyclic GMP hydrolysis by activated phosphodiesterase in photoreceptors” [J. Chem. Phys. 129, 145102 (2008)]. Reingruber, Jürgen; Holcman, David // Journal of Chemical Physics;1/7/2009, Vol. 130 Issue 1, p019901 

    A correction to the article "Estimating the rate constant of cyclic GMP hydrolysis by activated phosphodiesterase in photoreceptors," by Jürgen Reingruber and David Holcman, in a 2008 issue, is presented.

  • GMP, cyclic.  // Encyclopedic Reference of Molecular Pharmacology;2004, p427 

    The article presents an encyclopedia entry for the term "cyclic GMP," which refers to an intracellular messenger generated by guanylyl cyclase from guanosine triphosphate.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics